123 related articles for article (PubMed ID: 6931473)
1. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Dencker SJ; Malm U; Jørgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
[TBL] [Abstract][Full Text] [Related]
2. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Jrgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
[TBL] [Abstract][Full Text] [Related]
3. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Dencker SJ; Lepp M; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
[TBL] [Abstract][Full Text] [Related]
4. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Dencker SJ; Frankenberg K; Hansen V; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
[TBL] [Abstract][Full Text] [Related]
5. Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics.
Dencker SJ; Elgen K
Acta Psychiatr Scand Suppl; 1980; 279():5-9. PubMed ID: 6996425
[No Abstract] [Full Text] [Related]
6. Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Dencker SJ; Lepp M; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():64-76. PubMed ID: 6105763
[TBL] [Abstract][Full Text] [Related]
7. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
Martyns-Yellowe IS
West Afr J Med; 1994; 13(4):200-3. PubMed ID: 7756183
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Pinto R; Bannerjee A; Ghosh N
Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Walker CA
Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
Turbott J; Villiger J; Hunter L
Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Eufe R; Wegener G
Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
[No Abstract] [Full Text] [Related]
12. A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():92-103. PubMed ID: 6931474
[TBL] [Abstract][Full Text] [Related]
13. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
[TBL] [Abstract][Full Text] [Related]
14. Serum concentration of depot neuroleptics in tardive dyskinesia.
Fairbairn AF; Rowell FJ; Hui SM; Hassanyeh F; Robinson AJ; Eccleston D
Br J Psychiatry; 1983 Jun; 142():579-83. PubMed ID: 6882980
[TBL] [Abstract][Full Text] [Related]
15. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Ahlfors UG; Dencker SJ; Gravem A; Remvig J
Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
[TBL] [Abstract][Full Text] [Related]
16. Depot neuroleptics in a community mental health service.
Blake B
Br Med J; 1979 Jul; 2(6181):48-9. PubMed ID: 466266
[No Abstract] [Full Text] [Related]
17. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
Lipska B; Szukalski B; Nurowska K; Welbel L
Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
[No Abstract] [Full Text] [Related]
18. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
Wistedt B; Jørgensen A; Wiles D
Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
[TBL] [Abstract][Full Text] [Related]
19. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
Lipska B; Welbel L; Nurowska K; Szukalski B
Act Nerv Super (Praha); 1987 Dec; 29(4):270-3. PubMed ID: 3439426
[TBL] [Abstract][Full Text] [Related]
20. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
Chowdhury ME; Chacon C
Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
